Distribution of the HLA class I allele in chronic hepatitis C and its association with serum ALT level in chronic hepatitis C

被引:17
|
作者
Kondo, Y
Kobayashi, K
Kobayashi, T
Shiina, M
Ueno, Y
Satoh, T
Shimosegawa, T
机构
[1] Tohoku Univ, Grad Sch Med, Dept Gastroenterol, Aoba Ku, Sendai, Miyagi 9808574, Japan
[2] Tohoku Univ, Sch Hlth Sci, Sendai, Miyagi 9808575, Japan
[3] Furukawa City Hosp, Dept Internal Med, Fukukawa 9196183, Japan
[4] Sendai Natl Hosp, Dept Gastroenterol, Sendai, Miyagi 9830045, Japan
[5] Sendai Shakaihoken Hosp, Ctr Renal Dis, Sendai, Miyagi 9810912, Japan
来源
关键词
HLA class I allele; HLA-A2; CTL; cellular immune response; Japanese individuals;
D O I
10.1620/tjem.201.109
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
An essential process for resolution of viral infections is the efficient recognition and elimination of intracellular virus. Recognition of viral antigens in the form of short peptides associated with HLA class I molecule is a major task of CD8(+) cytotoxic T lymphocytes. In this study, we have evaluated the frequency of the HLA class I alleles in patients with chronic hepatitis C. HLA-B51, -B52, -B55, -B56, -B61, B70, -Cw1, -Cw3, and -Cw4 are less frequent in patients with chronic hepatitis C than in Japanese individuals. The frequency of HLA-A2 is slightly lower in the patients but tends to be higher in patients with normal alanine aminotransferase (ALT) level than in those with elevated ALT level (p = 0.07). Other HLA alleles are not significantly different between two groups. Comparison of HLA homozygosity at HLA-A and -B or -C or at two or three loci did not show a significant association with levels of serum ALT or with the clinical outcome of interferon therapy in patients with hepatitis C. These results suggest a possibility that the alterations of host response, which depends on genetic background, influence disease activities of HCV infection.
引用
收藏
页码:109 / 117
页数:9
相关论文
共 50 条
  • [21] Phlebotomy lowers serum alt and alphafetoprotein levels in patients with chronic hepatitis C.
    Lurie, Y
    BeerGabel, M
    Malnick, SDH
    Lambort, I
    Soumatzki, T
    Kaftory, A
    Ketter, D
    Illuz, M
    Rimon, E
    Morali, G
    Hirsch, A
    Broide, E
    Scapa, E
    Shapiro, M
    Pery, M
    Lichtman, G
    Goren, SB
    Bujanover, Y
    Bass, DD
    HEPATOLOGY, 1997, 26 (04) : 346 - 346
  • [22] SIGNIFICANCE OF SERUM HEPATITIS-C VIRUS CORE PROTEIN LEVEL IN PATIENTS WITH CHRONIC HEPATITIS-C
    ORITO, E
    MIZOKAMI, M
    SUZUKI, K
    OHBA, K
    OHNO, T
    KOIDE, T
    NAKANO, T
    LAU, JYN
    TANAKA, T
    TANAKA, S
    KOHARA, M
    HEPATOLOGY, 1995, 22 (04) : 1452 - 1452
  • [23] Association of killer immunoglobulin-like receptors and their HLA Class I ligands with progression of chronic hepatitis C virus infection
    Lopez-Vazquez, A.
    Rodrigo, L.
    Lopez-Larrea, C.
    TISSUE ANTIGENS, 2007, 69 : 241 - 242
  • [24] Association of Human Leucocyte Antigen Class I (HLA-A and HLA-B) With Chronic Hepatitis C Virus Infection in Egyptian Patients
    Mosaad, Y. M.
    Farag, R. E.
    Arafa, M. M.
    Eletreby, S.
    El-Alfy, H. A.
    Eldeek, B. S.
    Tawhid, Z. M.
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2010, 72 (06) : 548 - 553
  • [25] Synergistic influence of tapasin and HLA class I protection against chronic hepatitis C virus infection
    Ashraf, S.
    Knapp, S.
    Becford-Tackoir, C.
    Brooks, C.
    Little, A. -M.
    Alexander, G.
    Cramp, M.
    Khakoo, S. I.
    IMMUNOLOGY, 2011, 135 : 173 - 173
  • [26] Are platelet count and ALT level, markers of liver fibrosis in chronic hepatitis C (CHC)?
    Capretti, A
    Taddei, MT
    Spotti, D
    Belloni, G
    Ferrari, L
    Spalanzani, C
    Croce, G
    JOURNAL OF HEPATOLOGY, 2000, 32 : 227 - 227
  • [27] SYNERGISTIC INFLUENCE OF TAPASIN AND HLA CLASS I PROTECTION AGAINST CHRONIC HEPATITIS C VIRUS INFECTION
    Ashraf, S.
    Knapp, S.
    Becford-Tackoir, C.
    Brooks, C.
    Little, A-M
    Alexander, G.
    Cramp, M.
    Khakoo, S. I.
    GUT, 2011, 60 : A51 - A52
  • [28] Elevated serum amylase level in chronic hepatitis C infection.
    Simsek, H
    Arici, M
    Oksuzoglu, G
    GASTROENTEROLOGY, 1996, 110 (04) : A1327 - A1327
  • [29] Serum α-foetoprotein level predicts treatment outcome in chronic hepatitis C
    Males, Sylvia
    Gad, Rita Raafat
    Esmat, Gamal
    Abobakr, Hasan
    Anwar, Mohamed
    Rekacewicz, Claire
    El Hoseiny, Mostafo
    Zalata, Khaled
    Abdel-Hamid, Mohamed
    Bedossa, Pierre
    Pol, Stanislas
    Mohamed, Mostafa K.
    Fontanet, Arnaud
    ANTIVIRAL THERAPY, 2007, 12 (05) : 797 - 803
  • [30] Adiponectin serum level in chronic hepatitis C infection and therapeutic profile
    Peta, Valentina
    Torti, Carlo
    Milic, Natasa
    Foca, Alfredo
    Abenavoli, Ludovico
    WORLD JOURNAL OF HEPATOLOGY, 2015, 7 (01) : 23 - 31